Home › Funds › Affinity Asset Advisors, LLC › CLYM
Affinity Asset Advisors, LLC position in CLYM
CLIMB BIO INC · Health Care
Affinity Asset Advisors, LLC reported holding 972,000 shares of CLYM (CLIMB BIO INC) in its Q3 2026 13F filing — a position valued at US$11.1M, representing 0.52% of its reported portfolio and ranking #43 among its reported holdings. Affinity Asset Advisors, LLC has disclosed CLYM holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Affinity Asset Advisors, LLC's CLYM position evolved
Affinity Asset Advisors, LLC first disclosed a stake in CLYM in Q2 2024 at 1,670,661 shares (US$11.9M). The position peaked in Q2 2026 at 972,000 shares, worth US$12.7M. Across 10 filings, Affinity Asset Advisors, LLC increased the stake 2 time(s), trimmed it 4 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 972,000 shares valued at US$11.1M. Notable position changes include a 67% trim in Q4 2024 (shares fell 32% over the following quarter), a 200% increase in Q1 2025 (shares rose 2% over the following quarter), a 46% trim in Q1 2026 (shares rose 90% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 1.67M | $11.88M | New |
| Q3 2024 | 1.50M | $7.63M | Reduce |
| Q4 2024 | 500.00K | $900.00K | Reduce |
| Q1 2025 | 1.50M | $1.83M | Add |
| Q2 2025 | 1.50M | $1.86M | Hold |
| Q3 2025 | 1.30M | $2.61M | Reduce |
| Q4 2025 | 1.30M | $5.20M | Hold |
| Q1 2026 | 700.00K | $4.79M | Reduce |
| Q2 2026 | 972.00K | $12.67M | Add |
| Q3 2026 | 972.00K | $11.15M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CLYM and 13F data
CLYM (CLIMB BIO INC) is a Health Care company. 72 other funds we track also report a position in CLYM — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$147.4M), BRAIDWELL LP (US$36.5M), Cormorant Asset Management, LP (US$27.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CLYM
- RA CAPITAL MANAGEMENT, L.P. 11.30M sh · $147.36M · Q2 2026
- BRAIDWELL LP 2.80M sh · $36.48M · Q2 2026
- Cormorant Asset Management, LP 2.11M sh · $27.46M · Q2 2026
- Redmile Group, LLC 1.23M sh · $15.99M · Q2 2026
- GREAT POINT PARTNERS LLC 1.00M sh · $13.04M · Q2 2026
- ADAR1 Capital Management, LLC 822.65K sh · $10.73M · Q2 2026
- STEMPOINT CAPITAL LP 742.75K sh · $9.69M · Q2 2026
- Parkman Healthcare Partners LLC 563.48K sh · $7.35M · Q2 2026
- SUPERSTRING CAPITAL MANAGEMENT LP 521.08K sh · $6.79M · Q2 2026
- SPHERA FUNDS MANAGEMENT LTD. 483.75K sh · $6.31M · Q2 2026
- NAN FUNG TRINITY (HK) Ltd 360.65K sh · $4.14M · Q3 2026
- Ally Bridge Group (NY) LLC 249.17K sh · $3.25M · Q2 2026
More on Affinity Asset Advisors, LLC
FAQ
How long has Affinity Asset Advisors, LLC held CLYM?
Affinity Asset Advisors, LLC has disclosed CLYM holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
What is Affinity Asset Advisors, LLC's current position in CLYM?
As of Q3 2026, Affinity Asset Advisors, LLC holds 972.00K shares of CLYM (CLIMB BIO INC), valued at $11.15M, representing 0.52% of its reported portfolio and ranking #43.
Has Affinity Asset Advisors, LLC been buying or selling CLYM?
In the latest 13F filing (Q3 2026), Affinity Asset Advisors, LLC held unchanged its position in CLYM. The position peaked in Q2 2026 at 972.00K shares.
Which other funds hold CLYM?
Other major institutional holders of CLYM include RA CAPITAL MANAGEMENT, L.P., BRAIDWELL LP, Cormorant Asset Management, LP, among 72 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.